Chronic Kidney Disease
Omnivorous low-protein diet for CKD shows superior essential amino acid, nutrient levels
Compared with vegan and lacto-ovo low-protein diets for those with chronic kidney disease, an omnivorous low-protein diet is less likely to be deficient in essential amino acids and nutrients, findings in the Journal of Renal Nutrition show.
American Kidney Fund launches Patient Access Initiative
The American Kidney Fund announced the launch of its Patient Access Initiative in a press release. The initiative aims to provide insight and solutions to health care access issues among patients with kidney disease and their caregivers.
VIDEO: Smart-mobile app screens for CKD in minutes
In this video, Paula LeClair, MBA, MHCDS, U.S. general manager at Healthy.io and chairperson for the American Diabetes Association Board in New England, discusses how the Minuteful Kidney test can improve screening adherence for chronic kidney disease.
Evaluation helps clinicians identify patients at risk for transfer from PD to hemodialysis
ORLANDO — Clinicians who asked themselves, “Would I be surprised if this patient transferred from peritoneal dialysis to hemodialysis within 6 months?” helped them identify patients at risk, according to a presentation at ASN Kidney Week.
VIDEO: Dapagliflozin can be administered with sparsentan in healthy adults
ORLANDO — In this video from ASN Kidney Week, Jula Inrig, MD, chief medical officer of Travere Therapeutics Inc., discusses the use of dapagliflozin with sparsentan as treatment for IgA nephropathy and focal segmental glomerulosclerosis.
Obesity plus low muscle mass may increase CKD risk in type 2 diabetes
Sarcopenic obesity may increase the risk for chronic kidney disease among adults with type 2 diabetes, but low muscle mass without obesity was not associated with CKD, according to study results published in Obesity.
VIDEO: Tarpeyo reduces proteinuria, galactose-deficient IgA1 in IgA nephropathy
ORLANDO — In this video from ASN Kidney Week, Jonathan Barratt, MBChB, PhD, discusses Calliditas Therapeutics’ Tarpeyo treatment, previously known as Nefecon, for patients with IgA nephropathy.
Coaching improves diet quality, albuminuria in Black patients with hypertension, CKD
ORLANDO — In Black adults with hypertension and chronic kidney disease, coaching about purchasing food with high potassium improved diet quality and albuminuria, according to a presenter at ASN Kidney Week.
Early diagnosis of CKD can slow eGFR decline
In this video from ASN Kidney Week, Navdeep Tangri, MD, PhD, discusses the results of the REVEAL CKD study.
‘Clear’ reduction in CV, renal outcomes with SGLT2 inhibitors across all high-risk groups
CHICAGO — A meta-analysis of 13 large SGLT2 inhibitor trials, including the recently published EMPA-KIDNEY trial, indicates that the drug class reduces CV and renal outcomes across all high-risk groups, with and without type 2 diabetes.